We’ve enjoyed unprecedented growth in the US market so we were delighted to meet our current and new customers at the 14th annual Bioprocessing Summit in Boston from August 15th to 18th. The conference itself included seven streams and a range of training seminars across three days. We’ve found attendees at physical conferences to be extremely engaged having not been able to enjoy face-to-face contact for over two years.
The conference featured several educational and inspiring speakers including Dr. Nicholas Warne, Vice president of pharmaceutical research and development at Pfizer. His presentation on ‘lessons learned from the pandemic’ was eye opening and inspiring. His presentation outlined the approach taken by Pfizer, with their partner BioNTech, in the development, manufacture, and distribution of the Covid-19 vaccine drug product while reflecting on lessons that may, or may not, be applicable to future product development.
With each new conference, we learn more about our customer’s specific analytical needs and it’s been wonderful to now introduce our customers to a fully relaunched ChemStress, CellAi and of course our flagship product, ValitaTiter.
Presentation streams – Bioprocessing Summit Boston
Dr. Alessandra Prinelli, Technical Product Manager & Brian Murphy, Commercial Director
